
Clinical Program Tests Ibogaine for Neurodegenerative Diseases
Tijuana, Mexico — A new clinical program has launched to test ibogaine, a naturally occurring psychedelic, for support in treating neurodegenerative conditions like multiple sclerosis (MS). The initiative aims to provide therapeutic options in a safe, …